Bovine serum amine oxidases (BSAO) activities are depressed in cattle with primary copper deficiency and the levels correlate very well with the clinical symptoms associated with the syndrome (Mills e t af., 1975). The most common form of copper deficiency in the field, however, is due to increased dietary molybdenum. Cattle grazing pastures moderately high in molybdenum (ls30p.p.m.) and low in copper (7 p.p.m.) develop molybdenosis. Symptoms include diarrhoea, coat discoloration and bone and artery defects, with significant growth depression. The syndrome is of major economic importance.
Molybdenum is converted to thiomolybdates (MoO,S:&, where n = &2) by rumen bacteria (Dick e t al., 1975) , with subsequent absorption from the gut (Mason, 1981) . Di-(n = 2 ) and tri-thiomolybdate (n = 3) circulate bound to albumin in vivo and are relatively stable with half-lives in plasma of 12 and 35 h respectively. Thiomolybdates depress dietary copper absorption and interfere with copper metabolism systemically. Thiomolybdates also inhibit the phenylene diamine oxidase activity of ceruloplasmin in vitro (Kelleher & Mason, 1986) be displaced by addition of unlabelled trithiomolybdate (100 p~) before chromatography, and was identified as trithiomolybdate by its elution characteristics.
Studies in vitro with BSAO purified by the method of Yamada & Yasonubu (l962), indicated that molybdate, tetra-(n = 4) and tri-thiomolybdate did not inhibit the enzyme. Dithiomolybdate inhibited the enzyme by an apparent non-competitive mechanism. At concentrations above 8 O p~ no further inhibition was observed and 35% of the enzyme activity remained (Fig. 1) . Slope and intercept replots were hyperbolic. The rate of hydrolyses of the dithiomolybdate was not accelerated by the enzyme.
Since sulphide may be associated with dithiomolybdate (Weber e t al., 1979), a comparative kinetic analysis of inhibition with sulphide is underway. Because trithiomolybdate does not inhibit the enzyme in vitro, it is likely that hydrolysis in vivo to dithiomolybdate (Hynes e t al., 1985) occurs to account for the depression of BSAO activities observed in the experimental animals of this study.
Since dithiomolybdate appears to be a novel inhibitor of BSAO, further investigation of its interaction with the enzyme may provide a new insight into the mechanism of action of the enzyme, as well as providing more information on the biochemical pathogenesis of the molybdenum-related disease syndromes. , 1985) . The loss of cytochrome P-450-associated enzyme activities in adrenal cell and renal cell cultures has been ascribed to the accumulation of the major products of cytochrome P-450-mediated metabolism in these cells, e.g. cortisol and vitamin D, respectively, and the knowledge that metyrapone inhibits these biotransformations (Hornsby et al., 1985; Crivello, 1985) . Therefore we have evaluated if an analogous process underlies the loss of cytochrome P-450 in hepatocyte culture. Neither cortisol or l ,25-dihydroxycholecalciferol are produced by hepatocytes (Holick & Clark, 1978; Takemori & Kominami, 1984) and corticosteroids have been shown to protect against the loss of hepatocyte cytochrome P-450 (Paine et al., 1979a). Thus the role of cholesterol, being the skeleton of these molecules, in the loss of hepatocyte cytochrome P-450 has been investigated. Accordingly, the effects of the cyclic monoterpenes, cineole, menthol and cyclandelate, have been studied since these compounds are known inhibitors of hepatic cholesterol synthesis in vivo (Middleton et al., 1979 (Middleton et al., , 1983 Clegg et al., 1980) . Hepatocytes were isolated from 200g male C.D. rats (Charles River Ltd., Margate, Kent, U.K.) as previously described (Paine et al., 1979a) and in order to avoid the addition of exogenous cholesterol, were cultured in serum-free Williams medium E (Flow Laboratories, Irvine, Scotland, U.K.), containing 2pg of fibronectin/ml, M-hydrocortisone-2 I-sodium succinate and M-insulin. Metyrapone was dissolved directly in the culture medium while cineole, cyclandelate and menthol were added in dimethylformamide (0.2%, v/v, final concentration). All chemicals were from the Sigma Chemical Co. (Poole, Dorset, U.K.). After 4 h of culture and treatment the medium was changed to fresh medium containing the compound under study and 100 pM-sodium [2-I4C]acetate (Amersham International, Amersham, Bucks., U.K.) at specific radioactivity of 10m Ci/ mol. The cells were incubated for a further 18 h and the incorporation of [2-I4C]acetate into non-saponifiable lipid was determined (Aufenanger e f al., 1986) after the addition of [ Icr, 2cr(n)-3H]cholestero1 (Amersham International) to each sample to correct for extraction efficiency. Cytochrome P-450 and protein were determined as previously described (Paine et al., 1979b) .
The results in Table 1 show that neither cineole or cyclandelate, at the highest concentrations tolerated by the cells, inhibit cholesterol synthesis in rat he atocyte culture as determined by the incorporation of [2-' Clacetate into nonsaponifiable lipid. In fact cineole was found to increase significantly ( P < 0.05) the total incorporation of [2-I4C]acetate into non-saponifiable lipid by increasing the amount of radiolabel associated with the cells (Table 1) . Similarly, neither cineole, cyclandelate or menthol inhibited the loss of cytochrome P-450 in rat hepatocyte culture ( 
